Kairos Pharma (KAPA) Institutional Ownership $0.62 +0.01 (+0.98%) As of 05/16/2025 04:10 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartHeadlinesOwnershipSEC FilingsBuy This Stock Institutional Ownership Changes (13F Filings) for Kairos Pharma (NYSEAMERICAN:KAPA)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.31MNumber ofInstitutional Sellers(last 12 months)0 Get KAPA Insider Trade Alerts Want to know when executives and insiders are buying or selling Kairos Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Kairos Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025 Armistice Capital LLC1,404,000$1.31M0.0%N/A10.248% (Data available from 1/1/2016 forward) KAPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KAPA shares? During the previous two years, the following institutional investors and hedge funds held shares of Kairos Pharma shares: Armistice Capital LLC ($1.31M).Learn more on KAPA's institutional investors. Which institutional investors have been buying Kairos Pharma stock? The following institutional investors have purchased Kairos Pharma stock in the last 24 months: Armistice Capital LLC ($1.40M). How much institutional buying is happening at Kairos Pharma? Institutional investors have bought a total of 1,404,000 shares in the last 24 months. This purchase volume represents approximately $1.31M in transactions. Related Companies Tenaya Therapeutics Institutional Ownership Iterum Therapeutics Institutional Ownership LAVA Therapeutics Institutional Ownership Rani Therapeutics Institutional Ownership FibroBiologics Institutional Ownership Dyadic International Institutional Ownership Scilex Institutional Ownership Marinus Pharmaceuticals Institutional Ownership FibroGen Institutional Ownership Kezar Life Sciences Institutional Ownership This page (NYSEAMERICAN:KAPA) was last updated on 5/18/2025 by MarketBeat.com Staff From Our PartnersWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…For the first time in history, we have a president who understands crypto's potential to bypass the banking sy...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe $100 Backdoor Into Musk’s New AI EmpireElon Musk’s “Final Move” could change everything in AI—and while average investors can’t get a stake in it dir...Behind the Markets | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kairos Pharma, LTD. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kairos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KAPA Stock Free KAPA Stock Alerts